-
Two-Year Data of Tapered Dupilumab Shows High Effectiveness in Chronic Rhinosinusitis with Nasal Polyps With Nonsteroidal Anti-inflammatory Drug-Exacerbated Respiratory Disease
Elzinga, H. B. E., Otten, J. J., Cornet, M. E., Rinia, A. B., van der Lans, R. J. L., Fokkens, W. J., Reitsma, S. & PolyREG Consortium, Jun 2025, In: Allergy: European Journal of Allergy and Clinical Immunology. 80, 6, p. 1737-1745 9 p.Research output: Contribution to Journal › Article › Academic › peer-review
-
Almost Half of the Dupilumab-Treated Patients With Severe Chronic Rhinosinusitis With Nasal Polyps Achieve Remission in One Year
Otten, J. J., Elzinga, H. E., van der Lans, R. J. L., Fokkens, W. J., Reitsma, S. & PolyREG Consortium, Apr 2025, In: Allergy: European Journal of Allergy and Clinical Immunology. 80, 4, p. 1166-1168 3 p.Research output: Contribution to Journal › Comment / Letter to the editor › Academic
-
“Super-Responders” to Dupilumab Treatment in Patients With Primary Diffuse Chronic Rhinosinusitis With Nasal Polyps
Vonk, P. E., Otten, J. J., Elzinga, H. B. E., van der Lans, R. J. L., Adriaensen, G. F. J. P., Benoist, L. B. L., Hoven, D. R., Fokkens, W. J., Reitsma, S. & PolyREG Consortium, 2025, (E-pub ahead of print) In: Allergy: European Journal of Allergy and Clinical Immunology.Research output: Contribution to Journal › Article › Academic › peer-review
- All publications
